Clinical Trial Update: Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating eplerenone for chronic central serous chorioretinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinopathy

Drugs mentioned

• Inspra (eplerenone)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Central Serous Chorioretinopathy | Phase 2 | Status: UNKNOWN